Tag Archives: OSK

Top 10 Warren Buffett Stocks For 2017

Billionaire investor Warren Buffett is getting richer by the minute.

That’s because the Oracle of Omaha’s company Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B) has a portfolio full of dividend-yielding stocks.

Represented are Wells Fargo & Co. (NYSE: WFC), Coca-Cola Co. (NYSE: KO), and Kraft Heinz Co. (Nasdaq: KHC), just to name a few.

The Berkshire portfolio has 34 dividend stocks in total; of those, eight yield dividend returns in excess of 3% annually, according to Buffett’s latest SEC 13F filing on Feb. 14, 2017.

Top 10 Warren Buffett Stocks For 2017: Telecom Italia S.P.A.(TI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.29 percent. Meanwhile, top losers in the sector included Telecom Italia SpA (ADR) (NYSE: TI), down 4 percent, and Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 3 percent.

Top 10 Warren Buffett Stocks For 2017: Capstead Mortgage Corporation(CMO)

Advisors’ Opinion:

  • [By Amanda Alix]

    As the spread between short-term and long-terminterest rates began to contract, strangling profits, competition for MBSes also caused prices to rise. Other agency mREITs were nervous, too. CYS Investments (NYSE: CYS  ) noted at the time that QE3 turned the Federal Reserve into the sector’s biggest rival for mortgage bonds, and as spreads began to shrink, so did dividends. By December of last year, Annaly, Armour, and Capstead Mortgage (NYSE: CMO  ) had all trimmed their payouts.

Top 10 Warren Buffett Stocks For 2017: BlackLine, Inc. (BL)

Advisors’ Opinion:

  • [By Danny Vena]

    The month-end close process is among the most time-consuming and intensive hurdles accountants face each and every month. Ensuring that transactions are recorded in the proper period, reconciliations are completed, and recurring entries are posted often requires long hours and late nights. The process can be fraught with the potential for errors, discrepancies, and inefficiency. BlackLine, Inc. (NASDAQ:BL) seeks to change all that by bringing automation to the process.

Top 10 Warren Buffett Stocks For 2017: Great Plains Energy Inc(GXP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Westar Energy stock declined 8% after regulators at the Kansas Corporation Commissions blocked the sale of Westar to Great Plains Energy (NYSE:GXP). The $12.2 billion merger would have joined utilities in Kansas and Missouri. Great Plains had argued that the combination would produce nearly $2 billion in efficiency gains in the next 10 years, but regulators instead sided with those who had argued that the deal was too rich and would have required rate increases sooner rather than later. Great Plains stock was hardly affected at all by the decision, leading many to conclude that Westar had a lot more to lose from the deal falling through then Great Plains had to gain from a successful merger.

Top 10 Warren Buffett Stocks For 2017: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

Top 10 Warren Buffett Stocks For 2017: Endeavour Silver Corporation(EXK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

  • [By Manikandan Raman]

    Citing bullish outlook on silver prices, Peter Bures of Canaccord Genuity has started coverage of four silver producers: Pan American Silver Corp. (USA) (NASDAQ: PAAS), Coeur Mining Inc (NYSE: CDE), Hecla Mining Company (NYSE: HL), and Endeavour Silver Corp (NYSE: EXK). The brokerage also assumed coverage of Fortuna Silver Mines Inc (NYSE: FSM) with a Buy rating.

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.66 percent. Meanwhile, top losers in the sector included Endeavour Silver Corp (NYSE: EXK), down 22 percent, and Greif, Inc. (NYSE: GEF), down 10 percent.

  • [By Lisa Levin]

    On Monday, basic materials shares surged by 1.1 percent. Top gainers in the sector included Cliffs Natural Resources Inc (NYSE: CLF) and Endeavour Silver Corp (NYSE: EXK).

Top 10 Warren Buffett Stocks For 2017: Synacor, Inc.(SYNC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Synacor Inc (NASDAQ: SYNC) shares dropped 18 percent to $3.42. Synacor priced 5.715 million shares at $3.50 per share.

    Shares of Resources Connection, Inc. (NASDAQ: RECN) were down around 15 percent to $13.65 after the company posted downbeat quarterly results.

  • [By Monica Gerson]

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

    VAALCO Energy, Inc. (NYSE: EGY) is expected to post a quarterly loss at $0.11 per share on revenue of $18.59 million.

Top 10 Warren Buffett Stocks For 2017: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

Top 10 Warren Buffett Stocks For 2017: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

Top 10 Warren Buffett Stocks For 2017: Boardwalk Pipeline Partners L.P.(BWP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested mid cap natural gas pipeline stock Boardwalk Pipeline Partners, LP (NYSE: BWP) as a bullish/long trade:

stock

August lean hogs are trading at 77.92, up 0.57 cents/lb. October lean hogs are trading at 65.02, up 0.72 cents /lb. December lean hogs are trading at 59.00, up 0.60 cents/lb.

Lean hog futures are trading higher just after the open Wednesday.

Market chatter about weather and cash prices is making the rounds.

The U.S. Department of Agriculture (USDA) monthly cold storage report is due out Friday at 3:00 p.m. ET.

Posted-In: lean hog futuresFutures Commodities Markets

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Related Articles Cocoa Futures Move Down 7 Biggest Price Target Changes For Wednesday Finding Value In Bank ETFs

stock: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

stock: Celldex Therapeutics Inc(CLDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.57 percent. Meanwhile, top losers in the sector included Amicus Therapeutics, Inc. (NASDAQ: FOLD), down 9 percent, and Celldex Therapeutics, Inc. (NASDAQ: CLDX), down 9 percent.

  • [By Todd Campbell]

    The ability to develop game-changing new drugs that revolutionize patient care could cause shares in Axovant Sciences (NYSE:AXON), Celldex Therapeutics (NASDAQ:CLDX), and Esperion Therapeutics (NASDAQ:ESPR) to soar. However, success may be tough to come by, and that makes investing in these stocks a boom or bust proposition.

  • [By WWW.KIPLINGER.COM]

    Celldex Therapeutics, Inc. (CLDX) is the first of the major biotech stocks scheduled to release an update on a pretty important drug this quarter; look for news on Oct. 8 concerning melanoma treatment glembatumumab vedotin. And thats a firm date too. Celldex is slated to present an update on the therapy at the European Society for Medical Oncology Congress.

stock: Activision Blizzard, Inc(ATVI)

Advisors’ Opinion:

  • [By Peter Graham]

    In February 2016, King Digital Entertainment PLC (NYSE: KING) was acquired by Activision Blizzard, Inc (NASDAQ: ATVI) for $5.9 billion.

    A technical chart for Glu Mobile shows a November reversal with shares back above a key resistance or support level:

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Demitrios Kalogeropoulos]

    If the stock market is a game, Activision Blizzard (NASDAQ:ATVI) shareholders are winning. The stock is up 60% over the past 12 months (18% in just one day last week) compared to the broader market’s 20% boost.

  • [By Demitrios Kalogeropoulos]

    Activision Blizzard (NASDAQ:ATVI) is set to post earnings results for the key holiday sales period on Thursday, Feb. 9. The stock is trouncing the market over the last five years, but investors have pushed it lower since its last quarterly check-in.

stock: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

stock: Google Inc.(GOOG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yes, Chipotle is having a great run. It’s gained 27% so far this year, and traded a new 52-week high today. But Chipotle is also expensive–so expensive that the market appears to be treating it like another Amazon.com (AMZN), Tesla (TSLA), Apple (AAPL), or Alphabet (GOOG), Moas wrote in his downgrade today. He explains:

  • [By Daniel Sparks]

    Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) has put its first-quarter earnings release date on the calendar. The internet search giant will report results for its most recently ended quarter on Thursday, April 27. After missing estimates for earnings per share in its most recent quarter, investors will be watching the company’s profitability closely.

  • [By Chris Neiger]

    Or perhaps you’ve heard of a Nest programmable thermostat.Alphabet(NASDAQ:GOOG) (NASDAQ:GOOGL)owns Nest, which makes internet-connected thermostats that you can control via a smartphone or tablet, and learns your heating and cooling preferences the more you use it.

  • [By Daniel Sparks]

    Hastings was careful to emphasize that, unlike Facebook and Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) YouTube, Netflix is a paid service and is not ad supported. But he also noted that Netflix isn’t as entrenched in international markets as these companies.

  • [By Chris Neiger]

    For the mobile side, Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google has already released several iterations of its Cardboard headset, and recently released its new Daydream View headset. These allow users to use their own smartphones to power a VR device.

  • [By Adam Levine-Weinberg]

    Last week, Brand Finance came out with its annual listing of brand valuations. In a somewhat shocking finding, the consulting group declared that Apple (NASDAQ:AAPL) had lost its supremacy to Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google.

stock market sectors

Democratic presidential nominee Hillary Clinton

Everyone wants to know: When will the FBI release the Hillary Clinton interview notes?

The answer to that question is very soon…

As soon as tomorrow, in fact, reported CNN this morning.

The imminent release comes in response to numerous Freedom of Information Act (FOIA) requests made to the FBI by various media outlets.

The FBI’s report has become a hot commodity on Capitol Hill, where GOP lawmakers — and their constituents — want to know exactly how FBI Director James Comey and his bureau came to a decision not to recommend the indictment of Hillary Clinton on July 5…

Join the conversation. Click here to jump to comments…

stock market sectors: LM Ericsson Telephone Company(ERIC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) dropped about 2% on Tuesday to post a new 52-week low of $6.75 against a 52-week high of $10.58. Volume of around 6.1 million was about 40% above the daily average of around 4 million. The stock closed at $6.89 on Monday night. The company had no specific news Tuesday.

  • [By Paul Ausick]

    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) dropped 3.6% on Thursday to post a new 52-week low of $5.35 against a 52-week high of $10.58. Volume of about 28 million was about 6 times the daily average of around 4.8 million. The stock closed at $5.55 on Wednesday night. The Swedish network gear maker warned on revenues and earnings Wednesday morning.

  • [By Anders Bylund]

    That’s a huge potential market, and Whitehurst claims to run ahead of the pack right now. Red Hat has partnered up with everybody from telco specialists Ericsson (NASDAQ:ERIC) and Nokia (NYSE:NOK) to all-purpose networking giants Cisco Systems (NASDAQ:CSCO) and Huawei. All of these networking giants will battle for a slice of the 5G market — and Red Hat is poised to ride the coattails of pretty much any winner in that space.

stock market sectors: Dell Technologies Inc. (DVMT)

Advisors’ Opinion:

  • [By Lee Jackson]

    Avery familiar technology face was acquiring shares of Dell Technologies Inc. (NASDAQ: DVMT) last week. The legendary Michael Dell himself was purchasedshares in the newest incarnation of the famed Dell franchise. Heacquired a total of 254,545 shares at a very reduced price of $27.50, which could be option-related. The total for the trade was posted at $7 million.

stock market sectors: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

stock market sectors: Duluth Holdings Inc.(DLTH)

Advisors’ Opinion:

  • [By Jason Hall, Travis Hoium, and Brian Feroldi]

    In our ongoing search for just such quality growth stocks, we asked three of our contributors to pick out ones they think have high growth potential from here, and tell us why. They gave us a unique retailer that’s carving out a huge following in Duluth Holdings(NASDAQ:DLTH), a recovering fast-casual dining darling inChipotle Mexican Grill (NYSE:CMG), and a gaming and resorts giant,Wynn Resorts (NASDAQ:WYNN).

  • [By Lisa Levin]

    Duluth Holdings Inc (NASDAQ: DLTH) shares were also up, gaining 23 percent to $21.94 as the company reported upbeat results for its fourth quarter on Thursday.

  • [By Monica Gerson] Related DLTH After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Earnings Scheduled For April 7, 2016 Duluth Holdings' (DLTH) CEO Stephanie Pugliese on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha) Related GPS After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Gap Comps Down 6% In March; Shares Plunge Difficult March Comparisons Were Too High For Retailers To Beat (Seeking Alpha)

    Some of the stocks that may grab investor focus today are:

  • [By Monica Gerson]

    Duluth Holdings Inc (NASDAQ: DLTH) is projected to post its quarterly earnings at $0.28 per share on revenue of $133.21 million.

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

investment risk

In my very first article on Seeking Alpha, I made a buy pitch for Habit Restaurants (NASDAQ:HABT) and a short pitch for Shake Shack (NYSE:SHAK). The Shake Shack pitch has played out fairly well, with the stock down almost 50% during that time.

My buy recommendation for Habit is another story. Its stock is down more than 50% since I recommended it. It’s for that reason, that I thought it was well past time to reexamine my bull thesis to see if anything still holds true, and see what needs to be revised. But I also thought it would be fun to ask: “Will Habit ever be worth $1 billion?”

Original Bull Thesis

My original bull thesis was simple. Here it is in a bullet point nutshell:

Habit was profitable, Restaurant count was increasing without taking on debt, Which maintained a very healthy balance sheet. The chain is consistently increasing comparable sales, And, even without the aforementioned growth, Habit was trading at a discount compared to its pe ers.

All these factors – and the numbers associated – led me to believe that the chain would have a market cap greater than $1.5 billion by 2019. This translated to a share price of close to $80/share. That’s a six-bagger from today’s price, so it deserves a new look.

investment risk: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Abbott Laboratories (ABT) , Dycom Industries (DY) and Howard Hughes (HHC) .

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

  • [By Matt Hogan]

    AbbVie has distributed a significant amount of its earnings in the form of dividends (~60 percent) since the company spun off from Abbott Laboratories (NYSE: ABT) in 2013. The company appears to be trading at a 10 percent discount to fair value when applying similar assumptions in the 5-year dividend discount model as shown below.

investment risk: HHGregg, Inc.(HGG)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co all over the place,Aaron’s, Inc (NYSE: AAN) coming in flat for investorsandhhgregg, Inc (NYSE: HGG)severely underperforming:

  • [By Lisa Levin]

    hhgregg, Inc. (NYSE: HGG) shares dropped 37 percent to $0.820. hhgregg reported preliminary Q3 revenue of $453 million.

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 15 percent to $3.67. Vince Holding projects full-year sales and EPS to come in at or below the low end of its earlier issued outlook.

  • [By Daniel B. Kline]

    Regional electronics chain hhgregg (NYSE:HGG) has decided to close 88 stores and three distribution centers as part of its just-filed Chapter 11 bankruptcy protection plans. The company expects to emerge from bankruptcy in about 60 days and has received funding for the reorganization process from a non-disclosed source.

investment risk: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

  • [By Roberto Pedone]

    Liquidity Service (LQDT) is an online auction marketplace for surplus and salvage assets. This stock closed up 14.9% at $34.44 in Monday’s trading session.

    Monday’s Volume: 1.60 million

    Three-Month Average Volume: 402,622

    Volume % Change: 336%

    From a technical perspective, LQDT skyrocketed higher here right off its 50-day moving average of $30.94 with strong upside volume. This move briefly saw shares of LQDT trend back above its 200-day moving average at $34.60, before it closed just below that level at $34.44. Shares of LQDT are now quickly moving within range of triggering a big breakout trade. That trade will hit if LQDT manages to take out Monday’s intraday high of $35.21 and then once it clears some more near-term overhead resistance at $35.71 with high volume.

    Traders should now look for long-biased trades in LQDT as long as it’s trending above $32.67 or above $31.60 and then once it sustains a move or close above those breakout levels with volume that hits near or above 402,622 shares. If we get that breakout soon, then LQDT will set up to re-test or possibly take out its next major overhead resistance levels at $38 to $40.90.

investment risk: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Foreign Regional Banks: This industry declined 2 percent by 11:00 am with Bancolombia SA (ADR) (NYSE: CIB) moving down 3.7 percent. Bancolombia’s PEG ratio is 4.51.

  • [By Monica Gerson]

    Bancolombia SA (ADR) (NYSE: CIB) is expected to post its quarterly earnings at $0.77 per share on revenue of $945.66 million.

    Cellcom Israel Ltd. (NYSE: CEL) is estimated to post its earnings for the latest quarter.

  • [By Javier Hasse]

    Analysts at Credit Suisse downgraded shares of Bancolombia SA (ADR) (NYSE: CIB) from Outperform to Neutral, while boosting their price target from $38 to $40.

  • [By Matt Smith]

    Bancolombia appears attractively priced
    Another Colombian company that appears under-valued is the Andean country’s largest commercial bank Bancolombia (NYSE: CIB  ) . For the year-to-date Bancolombia’s share price fell 17% because of a weak second quarter bottom-line. This decline was primarily caused by the bank’s net income plunging by 41% year-over-year because of mark-to-market losses caused by the value lost in the bank’s securities portfolio.

investment risk: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

stock market books

Related VRX After-Hours Recap: Medivation, Valeant, CSX & More Valeant Perception Has Turned A Corner, Stifel Analysts Say Valeant Dives As Bondhoder Seeks Default; Buyout Buzz Lifts Medivation (Investor’s Business Daily)

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) investors may have been surprised yet again Tuesday afternoon as the company announced it received a notice of default from bondholders.

In a press release published at 5 p.m. EDT, Valeant highlighted the notice of default as related to the company's delayed 10-K filing. Valeant said the notice "does not accelerate any of the company's indebtedness" and reassured the 10-K is on schedule to filed on or before the previously disclosed April 29, 2016.

Valeant noted it has until June 11, 2016 to cure the default through the filing of the 10-K.

By the time the official company press release disclosing the notice of default hit newswires, shares of Valeant were already rebounding from after-hours lows. Shortly after Tuesday's closing bell, a Dow Jones report suggested a "big Valeant bond investor Centerbridge notified company of intention to call a default."

stock market books: Zumiez Inc.(ZUMZ)

Advisors’ Opinion:

  • [By Chris Lange]

    Zumiez Inc. (NASDAQ: ZUMZ) is set to report its fiscal second-quarter results on Thursday. The consensus estimates predicta net loss of $0.08 per share and $177.35 million in revenue. Shares were changing hands at $16.61 on Fridays close. The consensus price target is $15.20, and the stock has a 52-week range of $11.53 to $23.45.

stock market books: Constellium N.V.(CSTM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

    Qiwi PLC (NASDAQ: QIWI) is expected to report its quarterly earnings at $13.85 per share on revenue of $2.70 billion.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested that small cap aluminum products and solutions stockConstellium NV (NYSE: CSTM) is looking like a short-term long bullish trade:

stock market books: Connecticut Water Service, Inc.(CTWS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, utilities shares gained 0.14 percent. Meanwhile, top gainers in the sector included Artesian Resources Corporation (NASDAQ: ARTNA), and Connecticut Water Service Inc (NASDAQ: CTWS).

stock market books: Kohl’s Corporation(KSS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    One theme that’s become apparent is that consumers are betting that a Trump tax cut will lead to more money in their pockets. That’s good news for the so-called “trade-up” stocks like Nordstrom (JWN) and Kohl’s (KSS) .

  • [By Money Morning Staff Reports]

    2017 Retail Death No. 2: Kohl’s Corp. (NYSE: KSS): Kohl’s slashed its full-year forecast of earnings per share to $3.60-$3.65 just yesterday (Jan. 5) – down from $3.80-$4.00 roughly two months ago in November 2016. Its reason for doing so was comparable holiday sales, which fell 2.7% in 2016 from fourth-quarter 2015.

  • [By Lisa Levin]

    In trading on Thursday, cyclical consumer goods & services shares fell by 0.67 percent. Meanwhile, top losers in the sector included Kohl's Corporation (NYSE: KSS), down 20 percent, and Macy's Inc (NYSE: M), down 13 percent.

  • [By Joe Tenebruso]

    Other department-store chains, such as Macy’s (NYSE:M), J.C. Penney (NYSE:JCP), and Kohl’s (NYSE:KSS), have also seen their stock prices plummet as they struggle with falling traffic and declining comparable-store sales. Consumer buying habits continue to shift away from their core mall-based operations, with department-store sales down for 11 years in a row, according to data from the Commerce Department.

  • [By Jeremy Bowman]

    It was a rough 2016 holiday season for brick-and-mortar retailers. Department store shares got thumped last week after Macy’s (NYSE:M) and Kohl’s (NYSE:KSS) both lowered their full-year earnings guidance and said their comparable-stores sales dropped. Those two stocks fell by double digits.

stock market books: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

stock market books: SanDisk Corporation(SNDK)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Early on Friday, analysts at RBC Capital boosted the near-term estimates on SanDisk Corporation (SNDK), a manufacturer of data storage products, because a fire at SK Hynix’s factory should lead to favorable pricing over the next two quarters.

    “We see a favorable pricing environment as a result of SK Hynix’s fire, which threatens to curtail NAND output as the company likely re-purposes production back toward DRAM, resulting in lower than expected incremental NAND wafers vs. company’s plan of 170K/WPM,” RBC Capital analyst Freedman said. “Consequently, we see stronger pricing through EoY before SK Hynix ramps NAND toward normalized prod’t levels as DRAM resources are restored/replaced.”

    The analysts maintain an “Outperform” rating on SDNK and still see shares reaching $76. This price target suggests a 26% upside to the stock’s Thursday closing price of $60.08. Furthermore, they boosted SanDisk’s 2013 EPS estimates from $4.82 to $4.95.

    SanDisk shares were up a fraction during pre-market trading on Friday. The stock is up 38.11% year-to-date.